The use of dopamine agonists in the treatment of schizophrenia.
D000293:Adolescent; D000328:Adult; D001058:Apomorphine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004298:Dopamine / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D001058:Apomorphine; D004298:Dopamine